| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972711 | The Journal of Heart and Lung Transplantation | 2007 | 5 Pages |
Abstract
Preliminary findings suggest that adequate activity of the GPx-1-based anti-oxidant system before device placement is associated with patient survival up to 1 month, despite comparable baseline oxidative stress in patients who both survived and died (within 2 weeks post-LVAD).
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Raffaele BSc, Andrea MD, Valentina BSc, Filippo MD, Jonica BSc, Tiziano MD, Emanuele MD, Giuliana ChD, Claudio MD, Maria MD, Ettore MD, Oberdan MD,